Operative hysteroscopy versus ultrasound-guided electric vacuum aspiration for removal of retained products of conception: A prospective cohort study.
Dilation and Curettage
Hysteroscopy
Intrauterine adhesions
Placental remnants
Retained products of conception
Journal
European journal of obstetrics & gynecology and reproductive biology: X
ISSN: 2590-1613
Titre abrégé: Eur J Obstet Gynecol Reprod Biol X
Pays: Netherlands
ID NLM: 101750520
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
10
04
2023
revised:
14
08
2023
accepted:
24
08
2023
medline:
13
9
2023
pubmed:
13
9
2023
entrez:
13
9
2023
Statut:
epublish
Résumé
To compare intrauterine adhesion (IUA) formation after hysteroscopic removal (HR) of retained products of conception (RPOC) with IUA formation after ultrasound-guided electric vacuum aspiration (EVA) and externally validate the outcomes of an RCT. This prospective cohort study was conducted from April 2015 until June 2022 in 2 Dutch teaching hospitals and one Belgian university hospital. Women opting for EVA underwent the procedure as soon as possible. In the HR group, the therapeutic hysteroscopy was performed at least eight weeks after the end of pregnancy. Postoperatively, an office second-look hysteroscopy was offered to all patients. Women were included if they had been diagnosed with RPOC ranging from 1 to 4 cm on ultrasound and did not want to participate in the RCT. EVA was performed using a Karman cannula. Operative hysteroscopy consisted either of hysteroscopic morcellation with the TruClear™ System or the Intrauterine BIGATTI Shaver or cold loop resection with a bipolar resectoscope. Of 178 included women, 124 were treated with HR and 28 with EVA. Outcomes of HR and EVA did not differ significantly in terms of complications (5.6 % vs 3.6 %; p = 1.00). Second-look hysteroscopy showed IUAs in 14 of 91 women (15.4 %) after HR and in 1 of 16 (6.3 %) after EVA (p = .461). Completeness of removal was significantly higher (90.1 %) after HR than after EVA (68.8 %) (p = .035). Additional operative hysteroscopy was required in 14.3 % of the HR group versus 37.5 % in the EVA group (p = .036). In our cohort study, no significant differences in IUAs or complications were found. RPOC removal with HR was more often complete than removal with EVA, and additional therapeutic hysteroscopy was less frequently required after HR. These findings need to be correlated with those of RCTs. The study was registered in de Dutch Trial Register (NTR4923). Date of registration 23-11-2014. Date of first enrollment 01-01-2015. https://trialsearch.who.int/Trial2.aspx?TrialID=NTR4923.
Identifiants
pubmed: 37701632
doi: 10.1016/j.eurox.2023.100230
pii: S2590-1613(23)00055-8
pmc: PMC10493502
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100230Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
None.
Références
Curr Opin Obstet Gynecol. 2005 Aug;17(4):339-42
pubmed: 15976537
Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:19-22
pubmed: 24332096
Trials. 2015 Nov 03;16:495
pubmed: 26530985
Gynecol Minim Invasive Ther. 2021 Nov 05;10(4):203-209
pubmed: 34909376
Int J Epidemiol. 2010 Feb;39(1):89-94
pubmed: 19376882
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Eur J Obstet Gynecol Reprod Biol. 2004 May 10;114(1):69-74
pubmed: 15099874
Hum Reprod. 1998 Dec;13(12):3347-50
pubmed: 9886512
J Minim Invasive Gynecol. 2005 Jan-Feb;12(1):62-6
pubmed: 15904601
J Minim Invasive Gynecol. 2010 Sep-Oct;17(5):555-69
pubmed: 20656564
J Gynecol Obstet Hum Reprod. 2019 Mar;48(3):151-154
pubmed: 30553048
PLoS Clin Trials. 2006 May;1(1):e9
pubmed: 16871331
J Am Assoc Gynecol Laparosc. 2001 May;8(2):199-202
pubmed: 11342724
Minerva Ginecol. 2017 Feb;69(1):23-28
pubmed: 28116885
J Minim Invasive Gynecol. 2011 Nov-Dec;18(6):774-8
pubmed: 22024264
Am J Public Health. 2008 Jan;98(1):9-10
pubmed: 18048772
BMC Womens Health. 2022 May 25;22(1):190
pubmed: 35614405
Mayo Clin Proc. 2013 Oct;88(10):1108-14
pubmed: 24079680
Fertil Steril. 2016 Jan;105(1):156-64.e1-2
pubmed: 26453977
Hum Reprod Update. 2014 Mar-Apr;20(2):262-78
pubmed: 24082042
Hum Reprod. 1993 Mar;8(3):442-4
pubmed: 8473464
Sao Paulo Med J. 2007 Sep 6;125(5):261-4
pubmed: 18094891
Eur J Obstet Gynecol Reprod Biol. 1994 Dec;57(3):171-3
pubmed: 7713291
Gynecol Surg. 2012 Nov;9(4):453-456
pubmed: 23144643
J Minim Invasive Gynecol. 2013 Nov-Dec;20(6):796-802
pubmed: 24183271
J Minim Invasive Gynecol. 2016 Nov - Dec;23(7):1172-1180
pubmed: 27590568
J Biomed Inform. 2021 Sep;121:103870
pubmed: 34302957
J Minim Invasive Gynecol. 2011 Jan-Feb;18(1):100-3
pubmed: 21195960
JAMA. 2023 Apr 11;329(14):1197-1205
pubmed: 37039805
Minim Invasive Ther Allied Technol. 2011 Jan;20(1):14-7
pubmed: 20695832